Method for predicting cardiovascular events
US7081347B2 · kind B2 · utility
14Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2003 |
| Grant date | Jul 25, 2006 |
| Priority date | — |
| Expiry date | Feb 21, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/203332
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for assessing aspirin resistance and relative risk of a cardiovascular event in a patient taking aspirin is provided. The concentration of 11-dehydro-thromboxane B2 in a urine sample is measured and compared to a set of standardized quartile concentrations. A concentration of urinary 11-dehydro-thromboxane B2 that falls within the second, third, or fourth quartile is indicative of aspirin resistance and an elevated risk of a recurrent cardiovascular event.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.